Medical care expenditures associated with chronic kidney disease in adults with diabetes: United States 2011

Diabetes Research and Clinical Practice

Volumn 109, Issue 1, 2015, Pages 185-190

  Ozieh, Mukoso N ^a,b   Dismuke, Clara E ^b,c   Lynch, Cheryl P ^b,c   Egede, Leonard E ^b,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Chronic kidney disease; Cost; Diabetes; MEPS

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTHRITIS; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COVARIANCE; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH SURVEY; HISPANIC; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICALLY UNINSURED; MINORITY GROUP; RACE DIFFERENCE; SELF REPORT; UNITED STATES; URBAN POPULATION; ADOLESCENT; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ECONOMICS; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES; YOUNG ADULT;

EID: 84930821276     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.04.011     Document Type: Article

References (18)

1. Guariguata L., Whiting D.R., Beagley J., et al. Global estimates of diabetes prevalence in adults for 2013 and projections for 2035 for the IDF Diabetes Atlas. Diabetes Res Clin Pract 2014, 103(2):137-149.
2. Centers for Disease Control and Prevention National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014 2014, U.S. Department of Health and Human Services, Atlanta.
3. Centers for Disease Control and Prevention (CDC) National chronic kidney disease fact sheet: general information and national estimates on chronic kidney disease in the United States, 2014 2014, US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta.
4. Rao C., Adair T., Bain C., et al. Mortality from diabetic renal disease: a hidden epidemic. Eur J Public Health 2012, 22:280-284.
5. Lozano R., Naghavi M., Foreman K. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
6. Brown J.B., Pedula K.L., Bakst A.W. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999, 159(16):1873-1880.
7. Vupputuri S., Kimes T.M., Calloway M.O., et al. The economic burden of progressive chronic kidney disease among patients with type 2 diabetes. J Diabetes Complications 2014, 28(1):10-16.
8. U.S.Renal Data System USRDS 2013 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States 2013, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
9. Laliberte F., Bookhart B.K., Vekeman F., et al. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. J Manage Care Pharm 2009, 15(4):312-322.
10. The Medical Expenditure Panel Survey. Available online: http://meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp.
11. Manning W.G., Mullahy J. Estimating log models: to transform or not to transform?. J Health Econ 2001, 20:461-494.
12. Belotti F., Deb P., Manning W.G., et al. Tpm: estimating two-part models. Stat J 2012, 5(2):1-13.
13. Hardin J.W., Hilbe J.M. Generalized linear models and extensions. A stata press publication 2007, StataCorp LP, College Station. 2nd ed.
14. Barnett S.B.L., Nurmagambetov T.A. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol 2011, 127(1):145-152.
15. Stauffer M.E., Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS ONE 2014, 9(1):e84943. 10.1371/journal.pone.0084943.
16. Pelletier E.M., Boyung S., Ben-Joseph R., et al. Economic outcomes associated with microvascular complications of type 2 diabetes mellitus. Pharmacoeconomics 2009, 27(6):479-490.
17. Machlin S., Cohen J., Elixhauser A., et al. Sensitivity of household reported medical conditions in the medical expenditure panel survey. Med Care 2009, 47(6):618-625.
18. Stark C.S., Fradkin J.E., Saydah S.H., et al. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care 2013, 36:2271-2279.